Transurethral Incision of the Prostate (TUIP) for Benign Prostatic Hyperplasia
Skip to the navigationSurgery Overview
Transurethral incision of the prostate (TUIP)
may be done to treat
benign prostatic hyperplasia (BPH). The surgeon uses
an instrument inserted into the
urethra that generates an electric current or laser
beam to make incisions in the prostate where the prostate meets the bladder.
Cutting muscle in this area relaxes the opening to the bladder, decreasing
resistance to the flow of urine out of the bladder. No tissue is removed. It is
done under either
general or
spinal anesthetic.
What To Expect After Surgery
TUIP is a much less invasive procedure
than
transurethral resection of the prostate (TURP). You are typically able to go home after surgery. You may not be able to urinate and may need to have a catheter to
drain your bladder. For most men, this lasts for a week or less.
Why It Is Done
TUIP may be a good option for men
who have only slightly enlarged prostates and who are bothered a lot by their symptoms.
TUIP may be chosen instead
of TURP by men who:
- Are at higher risk for complications from
surgery and anesthetic, including men with serious health problems. TUIP
involves less blood loss and can be done more quickly than
TURP.
- Want to avoid the risk for retrograde ejaculation,
a condition in which semen flows backward into the bladder. This side effect is
more common with TURP than with TUIP.
How Well It Works
Symptoms improve after TUIP in about
8 out of 10 men.footnote 1 Men notice about a 73% improvement
in their
American Urological Association (AUA) symptom index
scores.footnote 1 For example, if you have a symptom score of 25
(severe), it could be reduced to about 7 (mild).
Short-term improvement in BPH symptoms is about the
same for TUIP as for TURP. Studies comparing the two types of surgery suggest
that the outcomes are similar. Men who have had TUIP generally are less
likely to develop retrograde ejaculation than men who have TURP. But men who have TUIP are more likely to need a second surgery.footnote 2
Risks
The possible risks of transurethral incision of
the prostate (TUIP) include the following:
- Retrograde ejaculation, in which semen flows
backward into the bladder, occurs in about 6 to 55 men out of 100.footnote 1 Retrograde ejaculation is not harmful.
- Erection problems in men who did not have one of these
problems before the surgery are reported in about 4 to 25 men out of
100.footnote 1
- Incontinence
occurs in fewer than 1 out of 100 men.footnote 1
- The need for a blood transfusion during surgery is
rare.
- For about 10 men out of 100, a second operation is needed
after 15 years.footnote 1
What To Think About
Surgery usually is not required to
treat BPH, but it may be a reasonable choice for some men. Choosing surgery
depends largely on your preferences and comfort with the idea of having
surgery. Things to think about include your expectations, the severity of your
symptoms, and the possibility of complications.
Men
who have severe symptoms often have great improvement in quality of life
following surgery. Men whose symptoms are mild may find that surgery does not
greatly improve quality of life. So men with only mild symptoms may want to think
carefully before having surgery to treat BPH.
Complete the surgery information form (PDF)(What is a PDF document?) to help you prepare for this surgery.
References
Citations
- Fitzpatrick JM (2012). Minimally invasive and endoscopic management of benign prostatic hyperplasia. In AJ Wein et al., eds., Campbell-Walsh Urology, 10th ed., vol. 3, pp. 2655-2694. Philadelphia: Saunders.
- AUA Practice Guidelines Committee (2010). AUA guideline on management of benign prostatic hyperplasia. Chapter 1: Guideline on the management of benign prostatic hyperplasia (BPH). Available online: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=bph.
Credits
ByHealthwise Staff
Primary Medical ReviewerE. Gregory Thompson, MD - Internal Medicine
Specialist Medical ReviewerJ. Curtis Nickel, MD, FRCSC - Urology
Current as ofMarch 14, 2017
Current as of:
March 14, 2017
Fitzpatrick JM (2012). Minimally invasive and endoscopic management of benign prostatic hyperplasia. In AJ Wein et al., eds., Campbell-Walsh Urology, 10th ed., vol. 3, pp. 2655-2694. Philadelphia: Saunders.
AUA Practice Guidelines Committee (2010). AUA guideline on management of benign prostatic hyperplasia. Chapter 1: Guideline on the management of benign prostatic hyperplasia (BPH). Available online: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=bph.